home / stock / edap / edap quote
Last: | $5.15 |
---|---|
Change Percent: | 0.0% |
Open: | $5.18 |
Close: | $5.15 |
High: | $5.18 |
Low: | $5.0703 |
Volume: | 11,940 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.15 | $5.18 | $5.15 | $5.18 | $5.0703 | 11,940 | 07-05-2024 |
$5.18 | $5.28 | $5.18 | $5.2812 | $5.15 | 4,249 | 07-04-2024 |
$5.18 | $5.28 | $5.18 | $5.2812 | $5.15 | 4,249 | 07-03-2024 |
$5.3 | $5.2 | $5.3 | $5.3 | $5.2 | 8,975 | 07-02-2024 |
$5.22 | $5.46 | $5.22 | $5.46 | $5.115 | 29,024 | 07-01-2024 |
$5.44 | $5.14 | $5.44 | $5.44 | $5.11 | 97,876 | 06-28-2024 |
$5.22 | $5.18 | $5.22 | $5.22 | $4.95 | 85,878 | 06-27-2024 |
$5.17 | $5.18 | $5.17 | $5.34 | $5.15 | 14,369 | 06-26-2024 |
$5.25 | $5.31 | $5.25 | $5.31 | $5.195 | 6,616 | 06-25-2024 |
$5.33 | $5.3406 | $5.33 | $5.3406 | $5.12 | 35,673 | 06-24-2024 |
$5.27 | $5.22 | $5.27 | $5.35 | $5.15 | 24,321 | 06-21-2024 |
$5.28 | $5.31 | $5.28 | $5.31 | $5.22 | 9,453 | 06-20-2024 |
$5.255 | $5.2 | $5.255 | $5.2999 | $5.19 | 11,664 | 06-19-2024 |
$5.255 | $5.2 | $5.255 | $5.2999 | $5.19 | 11,664 | 06-18-2024 |
$5.33 | $5.35 | $5.33 | $5.3651 | $5.18 | 11,716 | 06-17-2024 |
$5.38 | $5.2948 | $5.38 | $5.4066 | $5.2948 | 5,375 | 06-14-2024 |
$5.318 | $5.21 | $5.318 | $5.35 | $5.1 | 8,564 | 06-13-2024 |
$5.2701 | $5.14 | $5.2701 | $5.38 | $5.04 | 47,210 | 06-12-2024 |
$5.3 | $5.22 | $5.3 | $5.4 | $5.21 | 10,241 | 06-11-2024 |
$5.3 | $5.37 | $5.3 | $5.3764 | $5.22 | 13,034 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both Urology and Gynecology therapeutic applications LYON, France, June 3, 2024 - EDAP TMS S...
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Hea...
Strong Q1 2024 U.S. Focal One ® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023 Q1 2024 total revenue of EUR 14.9 million ($16.1 million USD) increased 0.8% over Q1 2023 Company to host...